Correlation Between Benchmark Botanics and Cipher Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Benchmark Botanics and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Benchmark Botanics and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Benchmark Botanics and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Benchmark Botanics and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Benchmark Botanics with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Benchmark Botanics and Cipher Pharmaceuticals.

Diversification Opportunities for Benchmark Botanics and Cipher Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Benchmark and Cipher is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Benchmark Botanics and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Benchmark Botanics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Benchmark Botanics are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Benchmark Botanics i.e., Benchmark Botanics and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Benchmark Botanics and Cipher Pharmaceuticals

Assuming the 90 days horizon Benchmark Botanics is expected to generate 1.72 times more return on investment than Cipher Pharmaceuticals. However, Benchmark Botanics is 1.72 times more volatile than Cipher Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  1.00  in Benchmark Botanics on August 29, 2024 and sell it today you would lose (0.66) from holding Benchmark Botanics or give up 66.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy8.67%
ValuesDaily Returns

Benchmark Botanics  vs.  Cipher Pharmaceuticals

 Performance 
       Timeline  
Benchmark Botanics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Benchmark Botanics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, Benchmark Botanics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Benchmark Botanics and Cipher Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Benchmark Botanics and Cipher Pharmaceuticals

The main advantage of trading using opposite Benchmark Botanics and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Benchmark Botanics position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.
The idea behind Benchmark Botanics and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope